Novartis Ag (NVS) Minority Interest (2009 - 2026)

Novartis Ag has disclosed Minority Interest across 18 years of filings, most recently posting $404.0 million for Q2 2026.

• In Q2 2026, Minority Interest rose 485.51% year-over-year to $404.0 million; the TTM figure through Jun 2026 stood at $404.0 million (up 485.51% YoY), while the FY2025 annual figure was $419.0 million, up 423.75% from the prior year.
• Minority Interest came in at $404.0 million for Q2 2026 at Novartis Ag, down from $415.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $422.0 million in Q3 2025 to a low of $69.0 million in Q2 2025.
• Average Minority Interest over 5 years is $166.7 million, with a median of $83.0 million recorded in 2023.
• Year-over-year, Minority Interest sank 59.17% in 2025 and surged 485.51% in 2026.
• Over 5 years, Minority Interest stood at $81.0 million in 2022, then advanced by 2.47% to $83.0 million in 2023, then decreased by 3.61% to $80.0 million in 2024, then jumped by 423.75% to $419.0 million in 2025, then decreased by 3.58% to $404.0 million in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were $404.0 million in Q2 2026, $415.0 million in Q1 2026, and $419.0 million in Q4 2025.